Transition to injecting drug use in Iran: A systematic review of qualitative and quantitative evidence

International Journal of Drug Policy

Volumn 26, Issue 9, 2015, Pages 808-819

  Rahimi Movaghar, Afarin ^a   Amin Esmaeili, Masoumeh ^b   Shadloo, Behrang ^a   Noroozi, Alireza ^a,c   Malekinejad, Mohsen ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

First injection episode; Harm reduction; Iran; Protective factors for injecting; Risk factors for injecting; Substance use; Systematic review

Indexed keywords

BIOINFORMATICS; CHARACTER; CURIOSITY; DATA ANALYSIS; DATA BASE; DRUG ABUSE PATTERN; DRUG SEEKING BEHAVIOR; DRUG TRAFFIC; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; IRAN; ONSET AGE; PEER PRESSURE; PLEASURE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; SHORT SURVEY; SOCIAL ASPECT; STATISTICAL MODEL; SYSTEMATIC REVIEW; THEMATIC ANALYSIS; HARM REDUCTION; META ANALYSIS; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS;

AGE OF ONSET; HARM REDUCTION; HEROIN DEPENDENCE; HUMANS; IRAN; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 84939267242     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2015.04.018     Document Type: Short Survey

References (84)

1. Abelson J., Treloar C., Crawford J., Kippax S., van Beek I., Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction 2006, 101(4):548-555. 10.1111/j.1360-0443.2006.01379.x.
2. Afsar Kazerooni Parvin, Amini Lari Mahmoud, Joolaei Hassan, Sabet Mozhgan, Hassan Abadi Ali Reza, Naghshvarian Mojtaba, et al. Prevalence of human immunodeficiency virus infection and related risk factors among injecting substance abusers in Shiraz, Southern part of Iran. Journal of Fundamentals of Mental Health 2009, 11(3):175-184. (abstract in English, full text in Persian).
3. Amin-Esmaeili M., Rahimi-Movaghar A., Haghdoost A.A., Mohraz M. Evidence of HIV epidemics among non-injecting drug users in Iran: A systematic review. Addiction 2012, 107(11):1929-1938. 10.1111/j.1360-0443.2012.03926.x.
4. Battjes R.J., Leukefeld C.G., Pickens R.W. Age at first injection and HIV risk among intravenous drug users. American Journal of Drug and Alcohol Abuse 1992, 18(3):263-273.
5. Bravo M.J., Barrio G., de la Fuente L., Royuela L., Domingo L., Silva T. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction 2003, 98(6):749-760.
6. Bridge J. Route transition interventions: Potential public health gains from reducing or preventing injecting. International Journal of Drug Policy 2010, 21(2):125-128. 10.1016/j.drugpo.2010.01.011.
7. Cepeda A., Kaplan C., Neaigus A., Cano M.A., Villarreal Y., Valdez A. Injecting transition risk and depression among Mexican American non-injecting heroin users. Drug and Alcohol Dependence 2012, 125(Suppl. 1):S12-S17. 10.1016/j.drugalcdep.2012.05.035.
8. Cheng Y., Sherman S.G., Srirat N., Vongchak T., Kawichai S., Jittiwutikarn J., et al. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct Journal 2006, 3:10. 10.1186/1477-7517-3-10.
9. Clatts M.C., Goldsamt L.A., Giang le M., Colon-Lopez V. Accelerated transition to injection among male heroin initiates in Hanoi, Vietnam: Implications for early harm reduction interventions. Journal of Community Health 2011, 36(6):999-1003. 10.1007/s10900-011-9400-8.
10. Des Jarlais D.C., Casriel C., Friedman S.R., Rosenblum A. AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. British Journal of Addiction 1992, 87(3):493-498.
11. Dolan K., Clement N., Rouen D., Rees V., Shearer J., Wodak A. Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?. Drug and Alcohol Review 2004, 23(3):281-286. 10.1080/09595230412331289437.
12. Dolan K., Salimi Sh., Nassirimanesh B., Mohsenifar S., Allsop D., Mokri A. Characteristics of Iranian women seeking drug treatment. Journal of Women's Health 2011, 20(11):1687-1691. 10.1089/jwh.2010.2694.
13. Draus P.J., Carlson R.G. Needles in the haystacks: The social context of initiation to heroin injection in rural Ohio. Substance Use and Misuse 2006, 41(8):1111-1124. 10.1080/10826080500411577.
14. Farhoudian A., Rahimi-Movaghar A., Mohammadi F., Fekri M. A study on Norjisak and Kerack in Tehran; symptoms and side effects, demand and supply situations, and chemical analysis (Project report) 2010, Tehran University of Medical Sciences (abstract in English, full text in Persian), Tehran.
15. Farhoudian A., Rahimi-Movaghar A., Rad Goodarzi R., Younesian M., Mohammadi M.R. Changes in the use of opioid drugs and available interventions in Bam during the first year after the earthquake. Hakim Research Journal 2006, 9(1):52-57. (abstract in English, full text in Persian).
16. Fennema J.S.A., Ameijden E.J.C., Hoek A., Coutinho R.A. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction 1997, 92(11):1457-1465.
17. Firestone M., Fischer B. A qualitative exploration of prescription opioid injection among street based drug users in Toronto: Behaviours, preferences and drug availability. Harm Reduction Journal 2008, 5:30. 10.1186/1477-7517-5-30.
18. Frajzyngier V., Neaigus A., Gyarmathy V.A., Miller M., Friedman S.R. Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence 2007, 89(2):145-152.
19. Fuller C.M., Vlahov D., Arria A.M., Ompad D.C., Garfein R., Strathdee S.A. Factors associated with adolescent initiation of injection drug use. Public Health Report 2001, 116(Suppl. 1):136-145.
20. Genberg B.L., Gange S.J., Go V.F., Celentano D.D., Kirk G.D., Mehta S.H. Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. American Journal of Epidemiology 2011, 173(7):829-836.
21. Haghdoost A.A., Osouli M., Sadjadi L., Mirzazadeh A., Navadeh S., Mostafavi A. HIV bio-behavioral surveillance of injecting drug users 2010 (Project report): Center for Communicable Disease Management 2012, Iran Ministry of Health AND Regional Knowledge Hub for HIV/AIDS Surveillance at Kerman University of Medical Sciences., (in Persian).
22. Haghdoost A.A., Sadjadi L., Mirzazadeh A., Navadeh S. Behavioral and serologic surveillance of injecting drug users and their primary sex partners in Tehran, Shiraz and Mashhad in 2010 (Project report) 2012, Center for Communicable Disease Management (CDC), Iran Ministry of Health AND Regional Knowledge Hub for HIV/AIDS Surveillance at Kerman University of Medical Sciences AND UNODC, (in Persian).
23. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases 2002, 186(11):1558-1564.
24. Harocopos A., Goldsamt L.A., Kobrak P., Jost J.J., Clatts M.C. New injectors and the social context of injection initiation. International Journal of Drug Policy 2009, 20(4):317-323.
25. Hunt N., Griffiths P., Southwell M., Stillwell G., Strang J. Preventing and curtailing injecting drug use: A review of opportunities for developing and delivering "route transition interventions. Drug and Alcohol Review 1999, 18:441-451.
26. Jafari S., Movaghar A.R., Baharlou S., Spittal P., Craib K.J.P. Trends of substance use in Southern Iran: A qualitative study. Internet Journal of Epidemiology 2008, 6(1):7p.
27. Jafari S., Rahimi-Movaghar A., Craib K.J.P., Baharlou S., Mathias R. A follow-up study of drug users in Southern Iran. Addiction Research & Theory 2010, 18(1):59-70. 10.3109/16066350902825930.
28. Jamali H. Rapid situation assessment of illegal substance use in Fooladshahr, Iran, 2009 2009, (Thesis for Master of Public Health), Tehran University of Medical Sciences, Tehran, (in Persian).
29. Kermode M., Longleng V., Singh B.C., Hocking J., Langkham B., Crofts N. My first time: Initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct Journal 2007, 4:19. 10.1186/1477-7517-4-19.
30. Kheirandish P., SeyedAlinaghi S., Jahani M., Shirzad H., Ahmadian M.S., Majidi A., et al. Prevalence and correlates of Hepatitis C infection among male injection drug users in detention, Tehran, Iran. Journal of Urban Health-Bulletin of the New York Academy of Medicine 2009, 86(6):902-908. 10.1007/s11524-009-9393-0.
31. Koram N., Liu H., Li J., Li J., Luo J., Nield J. Role of social network dimensions in the transition to injection drug use: Actions speak louder than words. AIDS and Behavior 2011, 15(7):1579-1588. 10.1007/s10461-011-9930-1.
32. Malekinejad M. Assessment of the use of respondent-driven sampling for studying populations most at risk of HIV infection 2008, (Dr. Ph.), University of California, Berkeley, (3353467).
33. Marshall B.D., Wood E., Shoveller J.A., Buxton J.A., Montaner J.S., Kerr T. Individual, social, and environmental factors associated with initiating methamphetamine injection: Implications for drug use and HIV prevention strategies. Preventive Science 2011, 12(2):173-180. 10.1007/s11121-010-0197-y.
34. Mehta S.H., Sudarshi D., Srikrishnan A.K., Celentano D.D., Vasudevan C.K., Anand S., et al. Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India. Addiction 2012, 107(2):349-358. 10.1111/j.1360-0443.2011.03602.x.
35. Meidani M., Farzaneh Sh., Ajami Baferani A., Hassan Zade A. Seroprevalence of HTLV1, 2 virus among injection drug addicts in Isfahan, 2007-2008. Journal of Shaheed Sadoughi University of Medical Sciences 2009, 17(4):286-290. (abstract in English, full text in Persian).
36. Mobaein A.R., Nasab Farhadi A. Compression of depression frequency in HIV positive and HIV negative among IV drug abusers. Journal of Guilan University of Medical Sciences 2011, 19(76):71-76. (abstract in English, full text in Persian).
37. Mohammad K., Majlessi F., Namdari Tabar H., Safarpor A., Laghaei Z., Cheshmberah A. Reasons for not using the harm-reduction package by injection additcs under coverage of Kermanshah Province DIC. Journal of School of Public Health and Institute of Public Health Research 2008, 6(1):11-22. (abstract in English, full text in Persian).
38. Mohraz M., Kheirandish P., Jahani M., Shirzad H., Ahmadian M.R. Assessment of HIV, HBV and HCV and syphilis prevalence among arrested injecting drug users in Tehran, 2006 (Project report): Iranian Research Center for HIV/AIDS 2009, Tehran University of Medical Sciences, (in Persian).
39. Morris M.D., Brouwer K.C., Lozada R.M., Gallardo M., Vera A., Strathdee S.A. "Injection first": A unique group of injection drug users in Tijuana, Mexico. American Journal of Addiction 2012, 21(1):23-30. 10.1111/j.1521-0391.2011.00194.x.
40. Motazakker M., Shokate Naghadeh M., Anosheh Mohamad The frequency of high-risk behaviors in drug addicted patients referring to methadone treatment centre in Urmia, West-Azerbaijan, 2010. Urmia Medical Journal 2012, 22(6):560-568. (abstract in English, full text in Persian).
41. Rapid situation assessment of drug abuse in Iran, 2007 (Project report) 2009, Danjeh Publication, Tehran, (in Persian). H. Narenjiha, H. Rafiei, A.R. Baghestani, R. Nouri, B. Ghafouri, L. Soleimaninia (Eds.).
42. Narenjiha H., Rafiei H., Baghestani A.R., Nouri R., Shirinbayan P., Farhadi M.H., et al. Rapid situation assessment of drug abuse in Iran, 2004 (Project report) 2005, Dariush Institute, Tehran, (in Persian).
43. Neaigus A., Gyarmathy V.A., Miller M., Frajzyngier V.M., Friedman S.R., Des Jarlais D.C. Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility. Journal of Acquired Immune Deficiency Syndromes 2006, 41(4):493-503. 10.1097/01.qai.0000186391.49205.3b.
44. Novelli L.A., Sherman S.G., Havens J.R., Strathdee S.A., Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug and Alcohol Dependence 2005, 77(3):303-309. 10.1016/j.drugalcdep.2004.08.021.
45. Oliveira M.L.A., Hacker M.A., Oliveira S.A.N., Telles P.R., Yoshida C.F.T., Bastos F.I. "The first shot": The context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil. Cadernos de Saúde Pública 2006, 22(4):861-870.
46. Ompad D.C., Ikeda R.M., Shah N., Fuller C.M., Bailey S., Morse E., et al. Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health 2005, 95(4):703-709.
47. Rafiey H., Narenjiha H., Shirinbayan P., Noori R., Javadipour M., Roshanpajouh M., et al. Needle and syringe sharing among Iranian drug injectors. Harm Reduction Journal 2009, 6-21. 10.1186/1477-7517-6-21.
48. Rahimi-Movaghar A. A review on the prevalence and the patterns of drug abuse in women in Iran. Social Welfare 2004, 3(12):203-226.
49. Rahimi-Movaghar A. A study of changes in drug abuse patterns in recent decades in Iran 2002, (Master of Public Health), Tehran University of Medical Sciences, Tehran, (in Persian).
50. Rahimi-Movaghar A., Amin-Esmaeili M., Aaraj E., Hermez J. Assessment of situation and response to drug use and its harms in the Middle East and North Africa, 2012. Middle East and North Africa Harm Rediction Association 2013, (MENAHRA).
51. Rahimi-Movaghar A., Amin-Esmaeili M., Haghdoost A.A., Sadeghirad B., Mohraz M. HIV prevalence amongst injecting drug users in Iran: A systematic review of studies conducted during the decade 1998-2007. International Journal of Drug Policy 2012, 23(4):271-278. 10.1016/j.drugpo.2011.09.002.
52. Rahimi-Movaghar A., Bayanzadeh S.A., Bolhari J., Alvandi M., Afshar M., rezaei D. A qualitative study of drug use in prisons of Iran (Project report) 2003, Prison Organization, Tehran, (in Persian).
53. Rahimi-Movaghar A., Mohammad K., Razaghi E.M. Trend of drug abuse situation in Iran: A three-decade survey. Hakim Research Journal 2002, 5(3):171-181. (abstract in English, full text in Persian).
54. Rahimi-Movaghar A., Noroozi A., Page K., Mohraz M., McFarland W., Malekafzali H., et al. Transition to injecting drug use and reverse transition among youth in Tehran, Iran; a qualitative study. (Project report) 2013.
55. Rahimi-Movaghar A., Razaghi E.M., Amin-Esmaeili M., Sahimi Izadian E., Baghestani A.R. The study of prevalence of infectious diseases among injecting drug abusers and their correlated factors in Tehran in 2006-2007 (Project report) 2008, Iranian National Center for Addiction Studies, Tehran, (abstract in English, full text in Persian).
56. Rahimi-Movaghar A., Razaghi E.M., Sahimi-Izadian E., Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. International Journal of Infectious Diseases 2010, 14(1):E28-E33. 10.1016/j.ijid.2009.03.002.
57. Razani N., Mohraz M., Kheirandish P., Malekinejad M., Malekafzali H., Mokri A., et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction 2007, 102(9):1472-1482.
58. Razzaghi E., Nassirimanesh B., Afshar P., Ohiri K., Claeson M., Power R. HIV/AIDS harm reduction in Iran. Lancet 2006, 368(9534):434-435. 10.1016/S0140-6736(06)69132-0.
59. Razzaghi E., Rahimi-Movaghar A., Hosseini M., Madani S., Chatterjee A. Rapid situation assessment of drug abuse in Iran 2005, Iranian Welfare Organization, Tehran, (in Persian).
60. Razzaghi E., Rahimi-Movaghar A. Injection drug use in Tehran, rapid assessment and response 2005, Tehran University of Medical Sciences, Tehran.
61. Razzaghi E., Rahimi-Movaghar A., Hosseini M., Madani S., Chatterjee A. Rapid situation assessment of drug abuse in Iran (Executive summary) 1999, Iranian Welfare Organization and UNDCP, Tehran.
62. Razzaghi E.M., Movaghar A.R., Green T.C., Khoshnood K. Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduct Journal 2006, 3:12. 1477-7517-3-12 [pii]. 10.1186/1477-7517-3-12.
63. Rhodes T., Bivol S., Scutelniciuc O., Hunt N., Bernays S., Busza J. Narrating the social relations of initiating injecting drug use: Transitions in self and society. International Journal of Drug Policy 2011, 22(6):445-454. 10.1016/j.drugpo.2011.07.012.
64. Rotondi N.K., Strike C., Kolla G., Rotondi M.A., Rudzinski K., Guimond T., et al. Transition to injection drug use: The role of initiators. AIDS and Behavior 2014, 18(3):486-494. 10.1007/s10461-013-0693-8.
65. Roy E., Boivin J.F., Leclerc P. Initiation to drug injection among street youth: A gender-based analysis. Drug and Alcohol Dependence 2011, 114(1):49-54.
66. Roy E., Godin G., Boudreau J.F., Cote P.B., Denis V., Haley N., et al. Modeling initiation into drug injection among street youth. Journal of Drug Education 2011, 41(2):119-134.
67. Roy E., Haley N., Leclerc P., Cedras L., Blais L., Boivin J.F. Drug injection among street youths in Montreal: Predictors of initiation. Journal of Urban Health 2003, 80(1):92-105. 10.1093/jurban/jtg092.
68. Roy E., Nonn E., Haley N. Transition to injection drug use among street youth - a qualitative analysis. Drug and Alcohol Dependence 2008, 94(1-3):19-29. 10.1016/j.drugalcdep.2007.09.021.
69. Saberi- Zafarghandi M.B., Rahimi-Movaghar A., Hajebi A., Amin-Esmaeili M., Razaghi E.M., Khastoo G., et al. Situation of drug use, addiction and related services in the Assaluyeh industrial area (South Pars gas field) in 2007 2008, Tehran University of Medical Sciences, Tehran, (in Persian).
70. Samimi-Rad K., Toosi M.N., Masoudi-nejad A., Najafi A., Rahimnia R., Asgari F., et al. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: A slight change in prevalence of HCV genotypes over time. Archives of Virology 2012, 157(10):1959-1965. 10.1007/s00705-012-1369-9.
71. Sánchez J., Chitwood D.D., Koo D.J. Risk factors associated with the transition from heroin sniffing to heroin injection: A street addict role perspective. Journal of Urban Health 2006, 83(5):896-910. 10.1007/s11524-006-9059-0.
72. Sharifi V., Amin-Esmaeili M., et al. Twelve-month prevalence and correlates of psychiatric disorders in Iran: Results from the Iranian Mental Health Survey, 2011. Archives of Iranian Medicine 2015, 18:76-84.
73. Shoghli A.R., Nasab S.N., Mosavi Fallahnezhad M., Momtazi S., Shirvan S., Tavasoli Karim B. Behavioral surveillance survey (BSS) among injection drug users (IDUs) in Zanjan-Iran. Journal of Zanjan University of Medical Sciences and Health Services 2011, 19(74):96-107. (abstract in English, full text in Persian).
74. Simmons J., Rajan S., McMahon J.M. Retrospective accounts of injection initiation in intimate partnerships. International Journal of Drug Policy 2012, 23(4):303-311.
75. Strang J., Griffiths P., Gossop M. Heroin in the United Kingdom: Different forms, different origins, and the relationship to different routes of administration. Drug and Alcohol Review 1997, 16:329-337.
76. Thorpe L.E., Ouellet L.J., Levy J.R., Williams I.T., Monterroso E.R. Hepatitis C virus infection: Prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. Journal of Infectious Diseases 2000, 182(6):1588-1594.
77. van Ameijden E.J., Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health 2001, 55(5):356-363.
78. Vazirian M., Kort G.D., Nassirimanesh B., Farhoudian A., Rad-Goudarzi R., Khazaeli A. Young people and drugs towards a comprehensive health promotion policy: Tehran report 2006, Asian Harm Reduction Network and United Nations Office on Drugs and Crime, Tehran, Iran.
79. Vlahov D., Fuller C.M., Ompad D.C., Galea S., Des Jarlais D.C. Updating the infection risk reduction hierarchy: Preventing transition into injection. Journal of Urban Health 2004, 81(1):14-19.
80. Young A.M., Havens J.R. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: A cross-sectional comparison and retrospective survival analysis. Addiction 2012, 107(3):587-596. 10.1111/j.1360-0443.2011.03635.x.
81. Zamani S. Integrated bio-behavioral surveillance for HIV infection among injecting drug users in Iran, 2007 (Project report) 2008, Center for Disease Managment, Ministry of Health, Tehran.
82. Zamani S., Farnia M., Tavakoli S., Gholizadeh M., Nazari M., Seddighi A.A., et al. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran. International Journal of Drug Policy 2010, 21(3):167-172. 10.1016/j.drugpo.2009.03.001.
83. Zamani S., Ono-Kihara M., Ichikawa S., Kihara M. Potential for sexual transmission of HIV infection from male injecting-drug users who have sex with men in Tehran, Iran. Sexually Transmitted Diseases 2010, 37(11):715-718. 10.1097/OLQ.0b013e3181e2c73f.
84. Zamani S., Radfar R., Nematollahi P., Fadaie R., Meshkati M., Mortazavi S., et al. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran. International Journal of Drug Policy 2010, 21(6):493-500. 10.1016/j.drugpo.2010.04.006.